ERBB2 and breast cancer: For instance, nanoliposomes (120–140 nm, PDI < 0.2) containing CTL peptide epitope derived from tumor-overexpressed rat HER2/neu protein (P5), a universal CD4+ T-helper cell epitope (PADRE), and MPLA were examined as a vaccine against breast cancer [163].